Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...

Massachusetts General Hospital's 2025 MGH ALS Young Investigator Awards went to three scholars doing ALS research.

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...

Clene will soon meet with the Food and Drug Administration to discuss analyses that could support an application for ...

ALS Awareness Month amplifies difficult emotions for columnist. It's one of the reasons why sharing is important.

Columnist Dagmar Munn considers when she decided to share the news that she had ALS — and it wasn't when she felt "ready" to ...

Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...

Columnist Kristin Neva, inspired by a Bon Iver song, investigates old journals as she thinks about the rhythm of her life.